Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
Lanikova L, Reading NS, Hu H, Tashi T, Burjanivova T, Shestakova A, Siwakoti B, Thakur BK, Pun CB, Sapkota A, Abdelaziz S, Feng BJ, Huff CD, Hashibe M, Prchal JT.
Lanikova L, et al. Among authors: shestakova a.
Oncotarget. 2017 Feb 14;8(7):11739-11747. doi: 10.18632/oncotarget.14340.
Oncotarget. 2017.
PMID: 28036300
Free PMC article.